Skip to content

Evaluation of capillary pathologies by nailfold capillaroscopy in patients with psoriasis vulgaris

Evaluation of capillary pathologies by nailfold capillaroscopy in patients with psoriasis vulgaris

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00012856
Enrollment
75
Registered
2017-12-07
Start date
2018-01-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40.0 M07.00

Interventions

Group 1: 25 patients with psoriasis vulgaris will be examined by nailfold capillaroscopy to evaluate the frequency, the extent, and the morphological patterns of changes in nailfold capillaries Grou

Sponsors

Universitäts-Hautklinik Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Moderate to severe psoriasis vulgaris and/or Psoriasis arthritis for at least 6 months. Signed written informed consent.

Exclusion criteria

Exclusion criteria: Patients under current exposure to any anti-psoriatic systemic therapy. Active ongoing inflammatory diseases. Patients that are unable to give informed consent.

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to investigate nailfold capillary patterns in 50 patients with psoriasis vulgaris alone or accompanying psoriasis arthritis compared to 25 healthy subjects. The changes will be evaluated only one time by means of nailfold capillaroscopy at the baseline visit.

Secondary

MeasureTime frame
A secondary objective of this study is to analyze the impact of the psoriasis area and severity score (PASI), nail psoriasis and demographic and clinical data e.g. age, gender, duration of the disease, manifest cardiovascular disease on nailfold capillaroscopy patterns. Date will be retrieved during the baseline visit.

Countries

Germany

Contacts

Public ContactHolger Haenssle

Universitäts-Hautklinik Heidelberg

Holger.haenssle@med.uni-heidelberg.de06221 56 8576

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026